Related Experiment Video
Updated: Jul 8, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Spondyloarthritis: a strong predictor of early coronary artery bypass grafting
I Hollan1, K Saatvedt, S M Almdahl
1The Feiring Heart Clinic AS, Feiring, Norway. i-hollan@online.no
Insights
Patients with spondyloarthritis (an inflammatory condition) experienced their first coronary artery bypass grafting (CABG) significantly earlier than those without the condition. This suggests spondyloarthritis may accelerate coronary artery disease.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Spondyloarthritides are a group of inflammatory diseases affecting the spine and joints.
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- The relationship between spondyloarthritides and the early onset of CAD requiring coronary artery bypass grafting (CABG) is not well-established.
Purpose of the Study:
- To investigate if patients with spondyloarthritides undergo their first CABG at a younger age compared to patients without this condition.
- To identify spondyloarthritis as a potential predictor of early-onset CAD.
Main Methods:
- A cohort of 3852 patients undergoing their first CABG between 2001-2005 were screened preoperatively for spondyloarthritides.
- Patient characteristics, including age and traditional cardiovascular risk factors, were compared between those with and without spondyloarthritides.
- Multivariate analysis was used to assess the predictive value of spondyloarthritis for early CABG.
Main Results:
- Spondyloarthritis was present in 0.78% of the CABG population.
- Patients with spondyloarthritides were significantly younger at the time of their first CABG (mean age 60.1 years) compared to controls (mean age 66.9 years).
- Spondyloarthritis was a stronger independent predictor of early CABG than traditional cardiovascular risk factors.
Conclusions:
- Spondyloarthritis is a significant predictor of early coronary artery bypass grafting, independent of traditional cardiovascular risk factors.
- The prevalence of spondyloarthritis appears higher in the CABG population, suggesting a potential link to accelerated coronary artery disease.
- Further research is warranted to elucidate the mechanisms behind accelerated CAD in patients with spondyloarthritides.
Objectives:
The main aim of the study was to examine whether patients with spondyloarthritides underwent their first coronary artery bypass grafting (CABG) at a younger age than those without spondyloarthritides.
Methods:
Patients who underwent their first CABG at the Feiring Heart Clinic during 2001-2005 were preoperatively screened for spondyloarthritides, and the cardiological assessment was registered. We compared the characteristics of patients with and without spondyloarthritides.
Results:
Of the 3852 patients undergoing their first CABG, 30 (0.78%) had spondyloarthritides. No statistically significant differences in traditional cardiovascular risk factors were found. The mean ages of patients with and without spondyloarthritides were 60.1 (SD = 8.7) and 66.9 (SD = 10.1) years, respectively. Spondyloarthritis was found by multivariate analysis to be a stronger independent predictor of early CABG than traditional cardiovascular risk factors [adjusted beta -6.2, p<0.001, 95% confidence interval (CI) -9.5 to -2.8]. Sixty per cent of spondyloarthritis patients and 52% of control patients had already suffered a myocardial infarction (p = 0.4).
Conclusion:
Spondyloarthritis was a stronger predictor of early CABG than most of the registered traditional cardiovascular risk factors. The prevalence of spondyloarthritis seemed to be higher in the CABG population than in the general population. These findings may indicate accelerated coronary artery disease (CAD) in spondyloarthritides.
Related Concept Videos
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations